NM_033124.5:c.398A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_033124.5(DRC2):​c.398A>G​(p.His133Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.371 in 1,613,544 control chromosomes in the GnomAD database, including 115,383 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H133Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.33 ( 9159 hom., cov: 32)
Exomes 𝑓: 0.38 ( 106224 hom. )

Consequence

DRC2
NM_033124.5 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.33

Publications

34 publications found
Variant links:
Genes affected
DRC2 (HGNC:29937): (coiled-coil domain containing 65) This gene encodes a sperm tail protein that is highly expressed in adult testis, spermatocytes and spermatids. The protein plays a critical role in the assembly of the nexin-dynein regulatory complex. Mutations in this gene result in primary ciliary dyskinesia. [provided by RefSeq, Nov 2013]
DRC2 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 27
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.7789006E-4).
BP6
Variant 12-48914501-A-G is Benign according to our data. Variant chr12-48914501-A-G is described in ClinVar as [Benign]. Clinvar id is 402501.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.467 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DRC2NM_033124.5 linkc.398A>G p.His133Arg missense_variant Exon 3 of 8 ENST00000320516.5 NP_149115.2 Q8IXS2-1
DRC2NM_001286957.2 linkc.-32A>G 5_prime_UTR_variant Exon 3 of 8 NP_001273886.1 B4DXQ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC65ENST00000320516.5 linkc.398A>G p.His133Arg missense_variant Exon 3 of 8 1 NM_033124.5 ENSP00000312706.4 Q8IXS2-1
ENSG00000272822ENST00000398092.4 linkc.385-10593T>C intron_variant Intron 4 of 4 3 ENSP00000438507.1 F5H423

Frequencies

GnomAD3 genomes
AF:
0.327
AC:
49763
AN:
151988
Hom.:
9150
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.433
Gnomad AMR
AF:
0.476
Gnomad ASJ
AF:
0.435
Gnomad EAS
AF:
0.471
Gnomad SAS
AF:
0.222
Gnomad FIN
AF:
0.372
Gnomad MID
AF:
0.395
Gnomad NFE
AF:
0.377
Gnomad OTH
AF:
0.361
GnomAD2 exomes
AF:
0.382
AC:
96026
AN:
251288
AF XY:
0.374
show subpopulations
Gnomad AFR exome
AF:
0.153
Gnomad AMR exome
AF:
0.553
Gnomad ASJ exome
AF:
0.437
Gnomad EAS exome
AF:
0.469
Gnomad FIN exome
AF:
0.383
Gnomad NFE exome
AF:
0.387
Gnomad OTH exome
AF:
0.389
GnomAD4 exome
AF:
0.375
AC:
548147
AN:
1461438
Hom.:
106224
Cov.:
40
AF XY:
0.372
AC XY:
270117
AN XY:
727052
show subpopulations
African (AFR)
AF:
0.155
AC:
5171
AN:
33466
American (AMR)
AF:
0.538
AC:
24060
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.432
AC:
11276
AN:
26128
East Asian (EAS)
AF:
0.477
AC:
18931
AN:
39690
South Asian (SAS)
AF:
0.224
AC:
19311
AN:
86226
European-Finnish (FIN)
AF:
0.387
AC:
20649
AN:
53400
Middle Eastern (MID)
AF:
0.377
AC:
2170
AN:
5762
European-Non Finnish (NFE)
AF:
0.382
AC:
424416
AN:
1111694
Other (OTH)
AF:
0.367
AC:
22163
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
17515
35030
52545
70060
87575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13228
26456
39684
52912
66140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.327
AC:
49784
AN:
152106
Hom.:
9159
Cov.:
32
AF XY:
0.331
AC XY:
24601
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.161
AC:
6664
AN:
41520
American (AMR)
AF:
0.476
AC:
7280
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.435
AC:
1510
AN:
3470
East Asian (EAS)
AF:
0.472
AC:
2435
AN:
5164
South Asian (SAS)
AF:
0.221
AC:
1068
AN:
4826
European-Finnish (FIN)
AF:
0.372
AC:
3934
AN:
10562
Middle Eastern (MID)
AF:
0.394
AC:
115
AN:
292
European-Non Finnish (NFE)
AF:
0.377
AC:
25618
AN:
67976
Other (OTH)
AF:
0.365
AC:
767
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1628
3255
4883
6510
8138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
482
964
1446
1928
2410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.374
Hom.:
28436
Bravo
AF:
0.338
TwinsUK
AF:
0.374
AC:
1386
ALSPAC
AF:
0.375
AC:
1445
ESP6500AA
AF:
0.161
AC:
711
ESP6500EA
AF:
0.382
AC:
3288
ExAC
AF:
0.370
AC:
44889
Asia WGS
AF:
0.360
AC:
1250
AN:
3478
EpiCase
AF:
0.389
EpiControl
AF:
0.392

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia 27 Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.79
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
12
DANN
Benign
0.46
DEOGEN2
Benign
0.00032
.;T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0092
N
LIST_S2
Benign
0.26
T;T
MetaRNN
Benign
0.00018
T;T
MetaSVM
Benign
-0.90
T
PhyloP100
3.3
PrimateAI
Benign
0.30
T
PROVEAN
Benign
0.56
N;N
REVEL
Benign
0.086
Sift
Benign
0.57
T;T
Sift4G
Benign
0.51
T;T
Polyphen
0.0
.;B
Vest4
0.018
MPC
0.057
ClinPred
0.0078
T
GERP RS
0.87
Varity_R
0.026
gMVP
0.031
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10747556; hg19: chr12-49308284; COSMIC: COSV57194967; COSMIC: COSV57194967; API